Clover Health reports Q2 EPS (2c) vs 1c last year

Reports Q2 revenue $477.6M, consensus $466.94M. “Our performance further demonstrates how our technology-first model drives better care management, above-market growth, and sustained profitability,” said Clover Health (CLOV) CEO Andrew Toy. “By leading with affordability, choice, and AI-driven clinical recommendations, we have achieved strong Medicare Advantage results this year to date, and importantly, better health outcomes for our members. Our recently published clinical whitepaper on chronic obstructive pulmonary disease shows that a relationship with a provider using Clover Assistant technology was correlated with fewer hospitalizations and readmissions.”